Search results
Results From The WOW.Com Content Network
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The COVID-19 pandemic was confirmed to have reached the U.S. Commonwealth of Kentucky on March 6, 2020, when Governor Andy Beshear 's office announced the first confirmed case in Cynthiana, Kentucky, and declared a state of emergency to ensure all entities had the necessary response resources. As of January 1, 2023, 1,667,275 cumulative cases ...
Operation Warp Speed ( OWS) was a public–private partnership initiated by the United States government to facilitate and accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics. [1] [2] The first news report of Operation Warp Speed was on April 29, 2020, [3] [4] [5] and the program was ...
There were 21.5 new COVID-19 admissions per 100,000 people, and 5.5% of hospital beds were used by coronavirus patients. The Lexington-Fayette County Health Department is hosting several free ...
Contour Airlines began serving Bowling Green–Warren County Regional Airport on August 29, 2016, with twice daily flights to Atlanta and twice weekly flights to Destin on a seasonal basis. This marked the first time Bowling Green had scheduled commercial service since 1972. The seasonal flights to Destin ended in late October.
Kentucky added 2,843 coronavirus cases last week — roughly 300 fewer than the week before — and none of the state’s counties are at the high COVID-19 community level, the latest data from ...
After more than 18,000 deaths from COVID-19 in Kentucky, the official coronavirus public health emergency ended May 11 — though the virus has not gone away. The U.S. Centers for Disease Control ...
COVID-19 pandemic. Sinopharm NVSI COVID-19 vaccine, also known as mutI-tri-RBD or NVSI-06-08, is a COVID-19 vaccine developed by National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of CNBG of Sinopharm. [1] [2]